Evidence map›Paper›PMID 32470413›Full record

ArticleThe Lancet. Neurology2020

MS-SMART study: systematic sampling bias concerns.

Lisa B Grech, Robert Hester, Stephen Stuckey, Michelle Allan, Ernest Butler

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Lisa B GrechDepartment of Health Sciences, Swinburne University, Hawthorn, VIC 3122, Australia; Melbourne School of Psychological Sciences, University of Melbourne, Parkville, VIC, Australia; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia; Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Electronic address: lbgrech@gmail.com.
Robert HesterMelbourne School of Psychological Sciences, University of Melbourne, Parkville, VIC, Australia.
Stephen StuckeySchool of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia; Department of Imaging, Monash Health, Clayton, VIC, Australia.
Michelle AllanDepartment of Neurology, Monash Health, Clayton, VIC, Australia.
Ernest ButlerSchool of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia; Department of Neurology, Monash Health, Clayton, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple SclerosisMultiple Sclerosis, Chronic ProgressiveNeuroprotective AgentsDouble-Blind MethodHumansSelection BiasNeuroprotective Agents

Identifiers

PMID32470413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.